Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by nodealson Aug 06, 2020 6:08pm
215 Views
Post# 31375961

FDA protocols

FDA protocols
 
Thanks to bullboard members who have contributed positive information and conduct themselves in a respectful manner. Good on you  for informing others members of the presence and the motivation (misrepresentation) of shorters.
 
This is bureaucracy at its best. The FDA in order to streamline the approval process in this tragic pandemic event immediately cause a delay! Some of the results of this  lost time will indeed delay in using the antigen as an important contribution to the control of fighting spread. Opening of schools, return to work and the possible reclosure of services.
 
Why the FDA, who are working closely with Sona, waited until July 29th to implement new protocols without giving heads-up to the CROs who were already  validating tests? Will previous approved test now have to repeat their verifications using the revised guidelines or will they be “grandfathered” . Will the approval be revoked?
 
When did Sona know and why not inform stockholders prior to today?
 
Don’t forget the investors who have suffered losses as a result. It is understood that risk is present in all investments, but this doesn’t absolve the poor handling of implementing these changes.
 
It is my belief that this is simply a delay. It is noted that others on this board feel the same. Therefore, I have invested more when the price dropped.
Bullboard Posts